Hydro Inject ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 13.9% 9.9% 8.9% 7.3%  
Credit score (0-100)  0 15 24 26 33  
Credit rating  N/A BB BB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  0.0 320 606 1,296 2,221  
EBITDA  0.0 320 606 1,060 1,350  
EBIT  0.0 315 599 1,052 1,343  
Pre-tax profit (PTP)  0.0 312.8 585.8 1,096.8 1,385.3  
Net earnings  0.0 241.8 450.4 855.1 1,066.8  
Pre-tax profit without non-rec. items  0.0 313 586 1,097 1,385  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 282 732 1,187 1,633  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 669 951 1,656 2,129  

Net Debt  0.0 -150 -443 -161 -533  
 
See the entire balance sheet

Volume 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 320 606 1,296 2,221  
Gross profit growth  0.0% 0.0% 89.4% 113.7% 71.4%  
Employees  0 0 0 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 669 951 1,656 2,129  
Balance sheet change%  0.0% 0.0% 42.2% 74.1% 28.6%  
Added value  0.0 320.1 606.3 1,059.6 1,350.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 40 8 -15 -15  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 98.4% 98.8% 81.2% 60.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 47.1% 72.4% 84.2% 73.2%  
ROI %  0.0% 111.8% 115.6% 114.4% 98.3%  
ROE %  0.0% 85.8% 88.8% 89.1% 75.7%  

Solidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  0.0% 42.2% 77.0% 71.7% 76.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -46.7% -73.1% -15.2% -39.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.0 1.0 3.2 3.0 2.8  
Current Ratio  0.0 1.4 3.7 3.1 3.9  
Cash and cash equivalent  0.0 149.6 443.2 160.6 533.0  

Capital use efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 136.4 584.4 990.4 1,433.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 1,060 1,350  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 1,060 1,350  
EBIT / employee  0 0 0 1,052 1,343  
Net earnings / employee  0 0 0 855 1,067